Cited by 35Liver Diseases and ImmunityHepatocellular Carcinoma Treatment and PrognosisPediatric Hepatobiliary Diseases and Treatments

Risk Factors for Survival and the Development of Hepatocellular Carcinoma in Patients with Primary Biliary Cirrhosis

Open access
Tomiyama, Yasuyuki, Takenaka, Kazuyuki, Kodama, Takahiro, Kawanaka, Miwa, Sasaki, Kyo, Nishina, Sohji, Yoshioka, Naoko, Hara, Yuichi +1 more·2013·Internal Medicine

Abstract

OBJECTIVE: Early diagnosis of hepatocellular carcinoma (HCC) is critical in the management of patients with primary biliary cirrhosis (PBC), since the prognosis of PBC has improved. The aim of this study was to investigate whether HCC development affects the prognosis of PBC and to identify the risk factors for HCC in Japanese patients with PBC. METHODS: We compared the survival rates between patients with HCC and those without and analyzed the risk factors for HCC development in 210 patients with PBC who were followed up for a median period of 8.5 years. RESULTS: HCC developed during follow-up in 11 patients (5.2%) and was diagnosed simultaneously at the time of diagnosis of PBC in five patients (2.4%) who were excluded from the analysis. A Kaplan-Meier analysis showed a significant difference in overall survival between the patients who did and did not develop HCC (p<0.001). A multivariate analysis revealed age (OR: 1.08, 95% confidence interval [CI]: 1.03-1.13, p=0.001), the albumin level (OR: 0.24, 95% CI: 0.10-0.56, p=0.001), the total bilirubin level (OR: 1.60, 95% CI: 1.09-2.36, p=0.017) and HCC development (OR: 2.97, 95% CI: 1.24-7.15, p=0.015) to be significant prognostic factors and identified only an advanced histological stage (Scheuer's classification III or IV, OR: 6.27, 95% CI: 1.80-21.83, p=0.004) to be a risk factor associated with HCC. CONCLUSION: HCC development significantly affects the survival of patients with PBC, and an advanced histological stage is the only risk factor associated with HCC development. These results highlight the important role of liver fibrosis in hepatocarcinogenesis in patients with PBC.

Integrity signals

Registry

Crossref · 10.2169/internalmedicine.52.0010

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Tomiyama, Y., Takenaka, K., Kodama, T., Kawanaka, M., Sasaki, K., Nishina, S., Yoshioka, N., Hara, Y., & Hino, K.
Affiliations
  • Kawasaki Medical School (JP)
  • Yamaguchi Prefecture Central Hospital (JP)
Venue
Internal Medicine
Published
2013
Volume
52
Issue
14
Pages
1553-1559
ISSN
  • 0918-2918 (ISSN-L)
  • 1349-7235
OpenAlex
W2040885256
Cited by
35
References
1
Citations by year
2025: 1 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 1 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 7 · 2015: 3 · 2014: 2 · 2013: 2
FWCI
2.90
Type
journal article
Language
en
Open access
Locations
  • Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ministry of Education, Culture, Sports, Science and Technology
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary biliary cirrhosis, hepatocellular carcinoma, hepatocarcinogenesis, risk factors, survival, prognostic factors, liver fibrosis, serum albumin, total bilirubin, age
MeSH terms
Aged, Female, Follow-Up Studies, Carcinoma, Hepatocellular, Humans, Liver Cirrhosis, Biliary, Liver Neoplasms, Male, Middle Aged, Retrospective Studies, Risk Factors, Survival Rate, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review